Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset-Reference-Cited by-同舟云学术

Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset

Published:2011-03 Issue:2 Volume:11 Page:197-206
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Rogers Geraint B,Hoffman Lucas R,Johnson Matt W,Mayer-Hamblett Nicole,Schwarze Jürgen,Carroll Mary P,Bruce Kenneth D

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/erm.10.117

Reference132 articles.

1. Management of Pulmonary Disease in Patients with Cystic Fibrosis

2. Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology

3. Balfour-Lynn IA, Elborn JS. Respiratory disease: infection. In:Cystic Fibrosis (3rd Edition). Hodson M, Geddes D, Bush A (Eds). Hodder Arnold, London, UK, 137–158 (2007).

4. Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best Practices: Imaging Strategies for Reduced-Dose Chest CT in the Management of Cystic Fibrosis–Related Lung Disease;American Journal of Roentgenology;2021-08

2. Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics;Journal of Proteome Research;2019-10-17

3. Efficacy of model-based iterative reconstruction in cystic fibrosis assessment using CT;Clinical Radiology;2019-07

4. Niche partitioning of a pathogenic microbiome driven by chemical gradients;Science Advances;2018-09-07

5. Testing the neutral theory of biodiversity with the microbiome dataset from cystic fibrosis patients;Medicine;2018-09